South Dakota Investment Council’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5M Hold
8,438
0.1% 190
2025
Q4
$4.11M Sell
8,438
-600
-7% -$279K 0.08% 206
2025
Q3
$3.79M Sell
9,038
-800
-8% -$269K 0.07% 219
2025
Q2
$2.83M Hold
9,838
0.05% 274
2025
Q1
$3.03M Buy
9,838
+200
+2% +$68.5K 0.06% 246
2024
Q4
$3.4M Hold
9,638
0.07% 233
2024
Q3
$3.45M Hold
9,638
0.07% 234
2024
Q2
$3.07M Sell
9,638
-200
-2% -$52.9K 0.06% 247
2024
Q1
$2.26M Sell
9,838
-800
-8% -$181K 0.05% 286
2023
Q4
$2.34M Hold
10,638
0.05% 304
2023
Q3
$2.4M Sell
10,638
-500
-4% -$115K 0.05% 277
2023
Q2
$2.46M Sell
11,138
-1,729
-13% -$383K 0.05% 298
2023
Q1
$2.88M Sell
12,867
-16,500
-56% -$4.07M 0.06% 260
2022
Q4
$8.17M Hold
29,367
0.18% 121
2022
Q3
$6.15M Hold
29,367
0.15% 134
2022
Q2
$6.92M Sell
29,367
-16,229
-36% -$3.3M 0.16% 126
2022
Q1
$8.18M Sell
45,596
-24,878
-35% -$4.74M 0.16% 131
2021
Q4
$15.2M Hold
70,474
0.25% 85
2021
Q3
$13M Sell
70,474
-2,500
-3% -$492K 0.23% 93
2021
Q2
$13.1M Buy
72,974
+1,600
+2% +$305K 0.23% 98
2021
Q1
$11.9M Sell
71,374
-8,448
-11% -$1.41M 0.2% 109
2020
Q4
$12.1M Hold
79,822
0.22% 101
2020
Q3
$8.06M Sell
79,822
-2,120
-3% -$233K 0.18% 112
2020
Q2
$9.91M Sell
81,942
-4,930
-6% -$555K 0.23% 93
2020
Q1
$8.24M Buy
86,872
+6,592
+8% +$627K 0.22% 87
2019
Q4
$7.07M Sell
80,280
-8,660
-10% -$762K 0.15% 148
2019
Q3
$7.09M Buy
88,940
+44,640
+101% +$3.59M 0.14% 159
2019
Q2
$3.46M Buy
44,300
+3,100
+8% +$290K 0.07% 207
2019
Q1
$4.84M Sell
41,200
-200
-0.5% -$23.3K 0.1% 167
2018
Q4
$4.51M Buy
41,400
+500
+1% +$58K 0.11% 160
2018
Q3
$5.23M Sell
40,900
-9,200
-18% -$1.14M 0.11% 158
2018
Q2
$5.67M Hold
50,100
0.12% 151
2018
Q1
$5.63M Hold
50,100
0.13% 139
2017
Q4
$7.41M Sell
50,100
-6,800
-12% -$864K 0.16% 123
2017
Q3
$6.67M Hold
56,900
0.14% 139
2017
Q2
$7.38M Buy
56,900
+5,300
+10% +$661K 0.16% 124
2017
Q1
$6.99M Sell
51,600
-13,627
-21% -$2.06M 0.14% 132
2016
Q4
$9.36M Sell
65,227
-3,173
-5% -$405K 0.2% 104
2016
Q3
$8.08M Buy
68,400
+6,700
+11% +$805K 0.17% 119
2016
Q2
$6.54M Buy
61,700
+13,000
+27% +$1.45M 0.14% 128
2016
Q1
$5.43M Buy
48,700
+19,900
+69% +$2.52M 0.12% 145
2015
Q4
$4.51M Hold
28,800
0.1% 158
2015
Q3
$3.78M Hold
28,800
0.09% 173
2015
Q2
$5.01M Hold
28,800
0.1% 153
2015
Q1
$4.97M Sell
28,800
-3,000
-9% -$457K 0.1% 153
2014
Q4
$4.12M Hold
31,800
0.08% 176
2014
Q3
$4.09M Buy
+31,800
New +$3.28M 0.08% 165

Other funds holding UTHR

South Dakota Investment Council's UTHR Position: Q1 2026 in Review

South Dakota Investment Council held its United Therapeutics (UTHR) position steady in Q1 2026 at 8,438 shares worth $5M. The position accounts for 0.1% of the portfolio, ranked #190.

South Dakota Investment Council first reported a position in UTHR in Q3 2014 and has held it in 47 quarters since. The position peaked at $15.2M in Q4 2021. 852 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • South Dakota Investment Council held 8,438 shares of United Therapeutics worth $5M as of Q1 2026.
  • South Dakota Investment Council left its United Therapeutics share count unchanged in Q1 2026.
  • United Therapeutics made up 0.1% of South Dakota Investment Council's portfolio in Q1 2026, its #190 holding.
  • South Dakota Investment Council first reported a position in United Therapeutics in Q3 2014 and has held it in 47 quarters since.
  • South Dakota Investment Council's United Therapeutics position peaked at $15.2M in Q4 2021.
  • 852 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on South Dakota Investment Council's 13F filing for Q1 2026, filed 18 May 2026.